Angiotensin II and norepinephrine release: interaction and effects on the heart
Authors:
- Markus P SchlaichMSMarkus P Schlaich
- David M KayeDKDavid M Kaye
- Elisabeth LambertELElisabeth Lambert
- Jacqui HastingsJHJacqui Hastings
- Duncan J CampbellDCDuncan J Campbell
- Gavin LambertGLGavin Lambert
- Murray D EslerMEMurray D Esler
- 1 May 2005
- journal article
- research article
- Published by Wolters Kluwer Health in Journal Of Hypertension
- Vol. 23 (5) , 1077-1082
Abstract
Angiotensin (Ang) II may enhance the influence of the sympathetic nervous system at various levels by facilitating norepinephrine (NE) release. We investigated whether such an interaction is evident in the human heart and whether it has an impact on left ventricular (LV) structure. Ang I and Ang II concentrations were determined in arterial and coronary sinus (CS) plasma samples in a group of normotensive (n = 10) and hypertensive (n = 18) subjects. Total systemic and cardiac NE spillover was measured using isotope dilution methodology and LV structure by echocardiography. Arterial and CS concentrations of Ang I and Ang II were similar in both groups (Ang II CS, 5.8 ± 4.0 versus 3.7 ± 3.1 fmol/ml; P = not significant), as was the Ang II/Ang I ratio (CS, 0.56 ± 0.17 versus 0.54 ± 0.22 fmol/fmol; P = not significant). Total systemic (223 ± 145 versus 374 ± 149 ng/min; P < 0.05) and cardiac NE spillover (11.7 ± 6.3 versus 19.4 ± 10.5 ng/min; P < 0.05) were increased in hypertensive patients, as was LV mass index (LVMI) (86.7 ± 14.7 versus 117.2 ± 19.4 g/m2; P < 0.001). LVMI correlated with cardiac NE spillover (r = 0.47; P < 0.02). No correlation was evident between CS Ang II and cardiac NE spillover (r = 0.001; P = not significant) or LVMI (r = −0.20; P = not significant). Arterial Ang II tended to correlate with total systemic NE spillover (r = 0.34; P = 0.081). When hypertensive subjects were divided into two groups with either high or low CS Ang II concentration, cardiac NE spillover and LVMI did not differ between the two groups. These findings suggest a growth-promoting effect of increased cardiac sympathetic tone on cardiomyocytes in hypertensive patients, but do not support the notion of a significant role of Ang II for norepinephrine release and LV hypertrophy in the hypertensive human heart.Keywords
This publication has 26 references indexed in Scilit:
- Regional norepinephrine spillover in response to angiotensin-converting enzyme inhibition in healthy subjectsJournal Of Hypertension, 2003
- Intracoronary blockade of angiotensin‐converting enzyme in humans: Interaction with cardiac sympathetic neurotransmission?Acta Physiologica Scandinavica, 1997
- Intracoronary Angiotensin II Potentiates Coronary Sympathetic Vasoconstriction in HumansCirculation, 1997
- Sex-specific determinants of increased left ventricular mass in the Tecumseh Blood Pressure Study.Circulation, 1994
- Effect of angiotensin II on noradrenaline release in the human forearmCardiovascular Research, 1994
- Prejunctional angiotensin II receptors. Facilitation of norepinephrine release in the human forearm.Journal of Clinical Investigation, 1994
- ACE inhibition attenuates sympathetic coronary vasoconstriction in patients with coronary artery disease.Circulation, 1992
- Echocardiographic assessment of left ventricular hypertrophy: Comparison to necropsy findingsThe American Journal of Cardiology, 1986
- Recommendations regarding quantitation in M-mode echocardiography: results of a survey of echocardiographic measurements.Circulation, 1978
- The Determinants of Plasma-Renin Activity in Essential HypertensionAnnals of Internal Medicine, 1978